Phospholipids and Membrane Phenomena Involved in the Release of Mediators of Anaphylaxis

  • Y. Pacheco
  • P. Fonlupt
  • A. F. Prigent
  • N. Biot
  • M. Perrin-Fayolle
  • H. Pacheco
Conference paper
Part of the FIDIA Research Series book series (FIDIA, volume 4)


The anaphylactic model is of particular interest in the study of inflammatory processes, but it can also inform us of some biological mechanisms in the central or peripheral nervous system. Histamine is now considered as a neuromediator (Schwartz et al., 1979a): histaminergic pathways have been studied in rat brain (Garbarg et al., 1980) and histamine H1 and H2 receptors have been described in the brain (Schwartz et al., 1979b). Non neuronal histamine-storing cells having properties strongly resembling those of typical mast cells have also been identified by biochemical and pharmacological approaches (Kruger, 1974). The functional role of mast cells in the central nervous system as in peripheral tissues is far from clear. In peripheral tissues it is generally assumed that they are involved in vascular control under particular pathophysiological conditions, i. e. during immune and inflammatory processes. It can be hypothezised that cerebral mast cells are involved in similar processes. Anaphylactic phenomena involved in tissues are closely interwoven with peripheral nervous system endings disturbances (Boushey et al., 1980). Interactions between inflammatory mediators and neuromediators have already been described (Besedovski et al., 1983). The immune system is now thought to be a sensory organ (Blalock, 1984). It seems probable that the sensory function of the immune system may mimic the neuroendocrine system in terms of a given stimulus eliciting a particular set of hormones and thus a physiological response. Molecular targets of neuromediators have been particularly studied in brain tissue; but these studies benefited from other studies on immune cells or adrenal medulla for example.


Mast Cell Histamine Release Allergic Subject Induce Histamine Release AdoHcy Hydrolase 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Benveniste J (1980) In: Oehling A (ed) Advances in Allergology. Pergamon Press. Oxford and New York, pp. 195–202.Google Scholar
  2. Benveniste J, Henson PM and Cochrane CG (1972) J Exp Med 136: 1356–1377.PubMedCrossRefGoogle Scholar
  3. Benyon RC, Church MK and Holgate S (1984) Biochem Pharmacol 33: 2881–2886.PubMedCrossRefGoogle Scholar
  4. Besedovski HO, Delrey AE and Sorkin E (1983) Immunology Today 4:342–346.CrossRefGoogle Scholar
  5. Blalock JE (1984) J Immunology 132: 1067–1070.Google Scholar
  6. Boushey HA, Holtzman MJ, Sheller JR and Nadel JA (1980) Am Rev Respir Dis 121: 389–413.PubMedGoogle Scholar
  7. Bruni A, Bigon E, Battistella A, Boarato E, Mietto L, and Toffano G (1984) Agents and Actions 14: 619–625.PubMedCrossRefGoogle Scholar
  8. Cantoni G (1952) J Am Chem Soc 74: 2942–2943.CrossRefGoogle Scholar
  9. Chien MM and Ashman RF (1984) Molec Immunol 21: 621–625.CrossRefGoogle Scholar
  10. Crews FT, Morita Y, Givney AMC, Hirata F, Siraganian RP and Axelrod J (1981) Arch Biochem Biophys 212: 561–571.PubMedCrossRefGoogle Scholar
  11. Dvorak AM, Dvorak HF, Peters SP, Shulman ES, MacGlashan DW, Pyne K, Harvey VS, Gallis J and Lichtenstein LM (1983) J Immunol 131: 2965–2975.PubMedGoogle Scholar
  12. Fonlupt P, Barailler J, Roche M, Cronenberger L and Pacheco H (1979) CR Acad Sci Paris 288: 283–286.Google Scholar
  13. Fonlupt P, Dubois M, Gallet H, Biot N and Pacheco H (1983) CR Acad Sci Paris 296: 1005–1007.Google Scholar
  14. Fonlupt P, Pacheco Y, Macovschi O, Dubois M, Biot N, Pacheco H (1984a) Clin Chim Acta 136: 13–18.PubMedCrossRefGoogle Scholar
  15. Fonlupt P, Rey C, Comte N, Dubois M and Pacheco H (1984b) CR Soc Biol 178: 45–51.Google Scholar
  16. Fonlupt P, Rey C and Pacheco H (1980a) J Neurochem 36: 165–170.CrossRefGoogle Scholar
  17. Fonlupt P, Rey C and Pacheco H (1982) Life Sci 3: 655–170.CrossRefGoogle Scholar
  18. Fonlupt P, Roche M, Cronenberger L and Pacheco H (1980b) Can J Pharmacol Physiol 58: 160–166.CrossRefGoogle Scholar
  19. Fonlupt P, Roche M and Pacheco H (1980c) Can J Pharmacol Physiol 58: 493–498.CrossRefGoogle Scholar
  20. Garbarg M, Barbin G, Llorens C et al (1980) In: Essman B (ed): Neurotransmitters, Receptors and Drug Action. Spectrum Publications, New York, pp. 179–202.Google Scholar
  21. Gibson KD, Wilson JD and Udenfriend S (1961) J Biol Chem 236: 673–679.PubMedGoogle Scholar
  22. Hattori H and Kanfer JN (1984) J Neurochemistry 42: 204–208.CrossRefGoogle Scholar
  23. Hirata F (1983) Biochimie Inflammation, pp. 61-66, Masson ed., Paris.Google Scholar
  24. Hirata F and Axelrod J (1978) Proc Natl Acad Sci. USA 75: 2348–2352.CrossRefGoogle Scholar
  25. Hirata F and Axelrod J (1980) Science 209: 1082–1090.PubMedCrossRefGoogle Scholar
  26. Hirata F, Strittmatter WJ and Axelrod J (1979) Proc Natl Acad Sci. USA 76: 368–372.CrossRefGoogle Scholar
  27. Imai A, Ishizuka Y, Nakashima S and Nozawa Y (1984) Arch Biochemistry Biophysics 232: 259–268.CrossRefGoogle Scholar
  28. Ishizaka T, Hirata F, Ishizaka K and Axelrod J (1980) Proc Natl Acad Sci. USA 77: 1903–1907.PubMedCrossRefGoogle Scholar
  29. Ishizaka T and Ishizaka K (1978) J Immunol 120: 800–805.PubMedGoogle Scholar
  30. Kerr JW and Ganderton MA (1982) Mediators of allergic tissue reaction. Symposium in London 82 ICACI. p. 3–46.Google Scholar
  31. Kruger PG (1974) Experientia 30: 810–811.PubMedCrossRefGoogle Scholar
  32. Marone G, Kagey-Sobotka A and Lichtenstein LM (1981) Clin Immunol Immunopathol 20: 231–239.PubMedCrossRefGoogle Scholar
  33. Marquardt DL, Nicolotti RA, Kennedy DA and Sullivan TJ (1981) J Immunology 127: 845–849.Google Scholar
  34. Moore JP, Johannsson A, Hesketh TR, Smith GA and Metcalfe JC (1984) Biochem J 221: 675–684.PubMedGoogle Scholar
  35. Morita Y, Chiang PK and Siraganian RP (1981) Biochem Pharmacol 30: 785–791.PubMedCrossRefGoogle Scholar
  36. Nath P, Josui AP and Agraval KP (1983) J Allergy Clin Immunol 72: 351–358.PubMedCrossRefGoogle Scholar
  37. Pacheco Y, Bensoussan P, Biot N, Duprat P, Fonlupt P, Prigent AF, Rey C, Dubois M, Pacheco H and Perrin-Fayolle M (1985) Prog Resp Res 19: 106–112.Google Scholar
  38. Pacheco Y, Bensoussan P, Biot N, Fonlupt P, Pacheco H, Perrin-Fayolle M and Gero M (1984a) Am Rev Respir Dis 129 (suppl.), A25 (abstract).Google Scholar
  39. Pacheco Y, Macovschi O, Biot N, Fonlupt P, Perrin-Fayolle M and Pacheco H (1984b) Clin Allergy 14: 37–43.PubMedCrossRefGoogle Scholar
  40. Prigent AF, Fonlupt P, Dubois M, Nemoz G, Pacheco H, Pacheco Y, Biot N and Perrin-Fayolle M (1984) Clin Chim Acta 143: 223–225.CrossRefGoogle Scholar
  41. Schellenberg RR (1980) Immunology 41: 123–129.PubMedGoogle Scholar
  42. Shinitzky M and Souroujon M (1979) Proc Natl Acad Sci USA 76: 4438–4440.PubMedCrossRefGoogle Scholar
  43. Schwartz JC, Barbin G, Baudry M et al (1979a) In: Essman B and Valzeili L (eds): Current Developments in Psychopharmacology vol. 5, pp. 173–261. Spectrum Publications. New York.Google Scholar
  44. Schwartz JC, Palacios JM, Barbin G et al. (1979b) In: Yellin TO (ed): Histamine Receptors. Spectrum Publications. New York. pp. 161–183.Google Scholar
  45. Sullivan TJ (1982) In: Becker EL and Austen KF (eds): Fourth Internat Symposium. Liss, New York, p. 229.Google Scholar
  46. Tolone G, Bonasera L and Pontieri GM (1982) Experientia 38: 966–968.PubMedCrossRefGoogle Scholar
  47. Ueland PM (1982): Pharmacol Rev 34: 223–253.PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1986

Authors and Affiliations

  • Y. Pacheco
    • 1
  • P. Fonlupt
    • 1
  • A. F. Prigent
    • 1
  • N. Biot
    • 1
  • M. Perrin-Fayolle
    • 1
  • H. Pacheco
    • 1
  1. 1.Centre Hospitalier Universitaire Lyon-Sud, Unité INSERM 205Lyon, VilleurbanneFrance

Personalised recommendations